Company Profile
Updated: 28-OCT-09PLIVA - Lachema A.S.
Joint Stock Company
Karasek 1, Brno, 621 33, Czech Republic
()420 541 127 111, 420 541 127 625 fax, http://www.lachema.cz
Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Research, development, manufacture and sale of drugs, diagnostic preparations and chemicals
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Restructuring of PLIVA's Operations in the Czech Republic.
InPR; 9/23/2009; 471 words; ...the acquisition by Teva of Barr/Pliva, agreement was reached to sell PLIVA-Lachema's diagnostic business and to close...other manufacturing activities at PLIVA-Lachema's Brno site effective end of 2009...
Pliva to divest of Pliva-Lachema's diagnostics ops.
ADP News Czech Republic; 9/21/2009; 458 words; ...the diagnostics operations of its Czech unit Pliva-Lachema, newswire SeeNews reported on Monday. Furthermore...divestment is part of the restructuring of Pliva-Lachema, which is in line with company's efforts to improve efficiency and profitability...
Publication No. WO/2009/100691 Published on Aug. 20, Assigned to PLIVA Lachema for Adamantylamino- Platinum Complex LA- 12 Polymorphic Form (Czech Inventors)
US Fed News Service, Including US State News; 8/25/2009; 407 words; ...polymorphic form (III) of the adamantylamino- platinum (IV) complex LA- 12. The patent has been assigned to PLIVA Lachema A.S., Brno, Czech Republic. According to an abstract posted by the World Intellectual Property Organization, the...
Publication No. WO/2009/100689 Published on Aug. 20, Assigned to PLIVA Lachema for Adamantylamino- Platinum Complex LA-12 Polymorphic Form (Czech Inventors)
US Fed News Service, Including US State News; 8/25/2009; 405 words; ...developed a polymorphic form of adamantylamino- platinum (IV) complex LA-12. The patent has been assigned to PLIVA Lachema A.S., Brno, Czech Republic. According to an abstract posted by the World Intellectual Property Organization, the...
Publication No. WO/2009/100690 Published on Aug. 20, Assigned to PLIVA Lachema for Adamantylamino-Platinum Complex LA-12 Amourphous Form (Czech Inventors)
US Fed News Service, Including US State News; 8/25/2009; 407 words; ...developed an amourphous form of the adamantylamino-platinum (iv) complex LA-12. The patent has been assigned to PLIVA Lachema A.S., Brno, Czech Republic. According to an abstract posted by the World Intellectual Property Organization, the...
Recent News Articles
- Pliva-Lachema Gains FDA Approval for Sterile Dosage Manufacturing.
M2 Presswire - May 29, 2007 - Research and Markets: Pliva-Lachema Gains FDA Approval for Sterile Dosage Manufacturing.
Business Wire - October 24, 2006 - PLIVA - Lachema Implements Sparta Systems' TrackWise(R) Software for Nine Quality Applications.
PR Newswire - March 03, 2006
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning